U.S. Markets open in 5 hrs 37 mins

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
67.82+1.69 (+2.56%)
At close: 04:00PM EST
67.97 +0.15 (+0.22%)
After hours: 07:58PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close66.13
Bid0.00 x 1000
Ask0.00 x 800
Day's Range63.64 - 68.63
52 Week Range56.34 - 138.52
Avg. Volume621,245
Market Cap4.621B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-6.54
Earnings DateMar 14, 2022 - Mar 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est122.89
  • Zacks

    The Zacks Analyst Blog Highlights: Pfizer (PFE), Beam Therapeutics, AbbVie, Merck and Glaxo

    Pfizer (PFE), Beam Therapeutics, AbbVie, Merck and Glaxo are highlighted in this analyst blog article.

  • Motley Fool

    Is Beam Therapeutics a Good Stock to Buy Now?

    Beam Therapeutics (NASDAQ: BEAM) recently signed a major research deal with Pfizer (NYSE: PFE) that could be worth up to $1.35 billion, and hardly anyone seemed to notice. Instead of surging higher in response to the Pfizer deal, Beam Therapeutics stock actually fell nearly 2% on the day of the announcement. Over the past few years, Pfizer has watched its peers experiment with CRISPR-based gene editing techniques without making any significant investments.


    Las Vegas Sands Stock Could See Better Luck Ahead

    After 35% plunge in 2021, the gambling stock looks attractive. Also, Wall Street opinions on Domino’s Pizza, Tower Semiconductor, Beam Therapeutics, and Kratos Defense & Security Solutions.